Trial Profile
Clinical and virological effects of NA inhibitors in pediatric patients with influenza B virus infection (between 4 years and 12 years old):an open-label,randomized study.
Status:
Suspended
Phase of Trial:
Phase II
Latest Information Update: 06 Feb 2019
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary) ; Peramivir (Primary)
- Indications Influenza B virus infections
- Focus Therapeutic Use
- 30 Jan 2019 Status changed from recruiting to suspended.
- 31 May 2016 New trial record